se gb


Viktor Drvota
Chief Executive Officer

Appointed as CEO 2017, previously CIO since 2016. Born 1965 M.D, Ph.D. Associate Prof. In Cardiology. Viktor Drvota has over 13 years of Venture Capital experience with several investements, significant fundraisings, IPOs and exits. He was responsible for Life science at SEB Venture Capital 2002 -2016. During his appointment at SEB VC he also served as a Board member in several biotech and Medtech companies such as Arexis AB, SBL Vaccin AB, Nuevolution AS, Index Pharma AB, Scibase AB, Airsonett AB among others. Before joining SEB in, Dr Drvota worked as Senior Consultant and Associate Professor in Cardiology at the Karolinska Institutet/hospital, Stockholm. Dr Drvota has experience from preclinical as well as clinical research in drug development and medical devices. Dr Drvota has 29 published research articles. Holdings in Karolinska Development: 1 608 418 warrants.


Christian Tange
Chief Financial Officer

Appointed in 2014.  Born 1966.  MSc in Economics and Business Administration. Christian Tange has over 15 years’ experience in international growth companies including 12 years within life science as global CFO for CMC Biologics from 2003-2012 and Business Controller for Warner Lambert Nordic from 1997-2000. Christian Tange has also acted as an industrial advisor and consultant for Private Equity Funds and Corporate Finance Advisors in M&A deals within life science.  Other appointments Board member of Dilafor AB and KDev Investments AB. Holdings in Karolinska Development: 70 278 shares, 402 105 warrants.


Ulf Richenberg
General Counsel

Appointed in 2008. Born 1955. Master of Laws. Ulf Richenberg has 25 years experience in business law, including positions as legal counsel of KIHAB, Esselte AB and Vattenfall, General Counsel of AB Stokab and Scribona AB and business law consultant at FOI. Other appointments Chairman of KCIF Fund Management AB. Board member of KD Incentive AB. Holdings in Karolinska Development: 38 205 shares, 402 105 warrants.


Yan Cheng
President Asia

Appointed in July 2017. Born 1985. BSc in Business Administration. Yan is a serial entrepreneur and investor in various Swedish and Chinese life science and technology companies. Yan also has experience of financial advisory and M&A between Asia and Europe, fundraising from Fortune 500 companies, and financial institutions. Holdings in Karolinska Development: 1,000 shares.


Elisabet Gimbringer

Employed since November 2015. Born 1965. Economics and Business education from Stockholm University. Elisabet has worked as an approved public accountant for 10 years, and as a financial manager, business controller and financial controller for a number of different companies and fields for the last 15 years. Other appointments Board member of KD Incentive AB. Holdings in Karolinska Development: 107 228 warrants.


Eva Montgomerie
Head of Accounting

Employed since october 2013, Employed within the group since 2007. Born 1958. MSc in Business and economics. Eva Montgomerie has worked within the bank and finance sector for 12 years, 10 years within the food and clothing sector and 7 years within life science.  Other appointments Finance manager in Dilafor AB and Pharmanest AB. Holdings in Karolinska Development: 107 228 warrants.


Felicia Rittemar

Employed since 2016. Born 1990. MSc in medical science with a major in Bioentrepreneurship from Karolinska Institutet. Holdings in Karolinska Development: 107 228 warrants.